Literature DB >> 6306918

Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.

J Icenogle, H Shiwen, G Duke, S Gilbert, R Rueckert, J Anderegg.   

Abstract

First-order kinetics of neutralization have usually been interpreted as evidence that a single antibody, binding at a critical site, neutralizes the infectivity of a virus particle. In such a case, if all the binding sites were critical, an average of one antibody bound per virion would be required to reduce the infectivity of a virus sample to 37% (1/e) of its initial infectivity. However, in the work reported here using a monoclonal antibody to poliovirus which inactivated with first-order kinetics, an average of four bound antibodies were required. These results are consistent with two different models: one in which only one-fourth of the antibody binding sites on the virion are critical for neutralization; the other, in which none of the sites is critical, but neutralization takes place instead in a stepwise fashion in which each bound antibody reduces the infectivity by a factor of 3/4. The maximum binding capacity of the virion for this monoclonal antibody was approximately 30 molecules. Since the 60 protein subunits of the poliovirus capsid are related by 30 twofold axes of symmetry, it is proposed that each monoclonal antibody binds bivalently to two protein subunits related by a twofold axis. Such a binding mode would crosslink pentamers, the basic structures in picornaviral assembly and dissociation. It is proposed that pentamer crosslinking is an important element in neutralization by this monoclonal antibody. Another antibody, which may neutralize by a different mechanism, is also discussed briefly.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306918     DOI: 10.1016/0042-6822(83)90154-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  Enhanced HIV-1 neutralization by antibody heteroligation.

Authors:  Hugo Mouquet; Malte Warncke; Johannes F Scheid; Michael S Seaman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

2.  Regulation of virus neutralization and the persistent fraction by TRIM21.

Authors:  W A McEwan; F Hauler; C R Williams; S R Bidgood; D L Mallery; R A Crowther; L C James
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.

Authors:  Joshua S Klein; Priyanthi N P Gnanapragasam; Rachel P Galimidi; Christopher P Foglesong; Anthony P West; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

4.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.

Authors:  F M Ruggeri; H B Greenberg
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

6.  Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.

Authors:  M J Grubman; D O Morgan; J Kendall; B Baxt
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

7.  Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.

Authors:  K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.

Authors:  A De Logu; R A Williamson; R Rozenshteyn; F Ramiro-Ibañez; C D Simpson; D R Burton; P P Sanna
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

9.  Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1.

Authors:  P J Klasse; J P Moore
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.

Authors:  C Wohlfart
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.